US health officials are considering RSV shots for older adults as vaccine makers like GSK aim to maintain market dominance. Plans to expand RSV vaccine usage face obstacles, leading to a decline in vaccine makers' stocks after CDC advisers change recommendations. CDC strengthens endorsement of RSV shots for the oldest Americans.
US health officials strengthen endorsement of RSV shots for oldest Americans https://t.co/Z49Ymm6UuG
Vaccine makers’ stocks fall as CDC advisers shift RSV-shot recommendations https://t.co/TgCjCMDA9K
Makers of #RSV vaccines for older adults saw their plans to try to expand usage hit a significant hurdle on Wednesday. https://t.co/7jAWjwW0W6
US advisers to consider RSV shots as drugmaker GSK looks to keep market lead https://t.co/mRSqlTIsrE https://t.co/mRSqlTIsrE
US advisers to consider RSV shots as GSK looks to keep market lead https://t.co/PJyOfenefe https://t.co/PJyOfenefe